Literature DB >> 7775944

Measles antibodies in women and infants in the vaccine era.

M A Kacica1, R A Venezia, J Miller, P A Hughes, M L Lepow.   

Abstract

The present investigation was done to determine whether measles enzyme immune assay (EIA) absorbency values were lower in women born in the vaccine era after 1963 and their infants in an upstate New York metropolitan area, an area of low measles incidence during the past 10 years compared with women born before the measles vaccine era who had natural measles. Aliquots of 202 sera from mother-infant pairs collected for other purposes from November 1990 to June 1991 at Albany Medical Center Hospital were tested by EIA. The demographic data available for analysis were maternal age and infant gestational age. Measles mean absorbency values were analyzed according to maternal age. Of 202 mother-infant pairs, 30% of mothers and 17% of their infants were seronegative (EIA < 0.16). Mothers born before 1963 and their infants had significantly higher mean EIA absorbency values than mothers born after 1963 and their infants (P < 0.002). The percent seropositive for measles antibodies by EIA for mothers born before 1963 and their infants, 87% and 94%, respectively, was significantly higher than the percent seropositive for mothers born after 1963 and their infants, 61% and 69%, respectively (P = 0.0001). Since the mean measles antibodies as measured by EIA absorbency were significantly lower in the mothers born after 1963 and their infants compared with women born before the vaccine era, the strategy for measles control in the future may have to include lowering the age of infant immunization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775944     DOI: 10.1002/jmv.1890450220

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.

Authors:  C Nicoara; K Zäch; D Trachsel; D Germann; L Matter
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women.

Authors:  R Brugha; M Ramsay; T Forsey; D Brown
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

3.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

Review 4.  Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants.

Authors:  Siyuan Hu; Nicola Logan; Jiratchaya Puenpa; Nasamon Wanlapakorn; Sompong Vongpunsawad; Yong Poovorawan; Brian J Willett; Margaret J Hosie
Journal:  Vaccine       Date:  2022-02-05       Impact factor: 3.641

5.  Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.

Authors:  Jolice P van den Berg; Elisabeth A M Westerbeek; Gaby P Smits; Fiona R M van der Klis; Guy A M Berbers; Ruurd M van Elburg
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.